FDA Inspection
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd. – FDA Inspection, Feb 22, 2019
Record Details
This FDA Inspection record concerns Qilu Pharmaceutical Co., Ltd., with an inspection on February 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 34945e69-b9f9-4aaf-8d2b-90f401ee3bf2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1088395
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Qilu Pharmaceutical Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2025 | Not classified | Office of Inspections and Investigations | |
| March 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 1, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qilu Pharmaceutical Co., Ltd.
- FDA Inspection 1269032 - 2025-04-04
- FDA Inspection 1048729 - 2018-03-09
- FDA Inspection 989208 - 2016-09-23
- FDA Inspection 855751 - 2013-10-25
- FDA Inspection 674203 - 2010-07-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.